94 results
Page 4 of 5
6-K
EX-99.1
7iy25c
10 Sep 20
Report of Foreign Private Issuer
3:18pm
6-K
EX-99.3
a5sxknqbvrua5 bk
12 Aug 20
Report of Foreign Private Issuer
8:27am
6-K
EX-99.1
ruhq9h8ocpxfdn 1y
6 Aug 20
Report of Foreign Private Issuer
4:02pm
6-K
EX-1.1
5ea1grcnaovo 6s0
20 May 20
Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares
4:14pm
424B5
zore cfphocpj7grs
20 May 20
Prospectus supplement for primary offering
4:08pm
424B5
debk86q
18 May 20
Prospectus supplement for primary offering
4:11pm
6-K
EX-99.1
8ie7dtt9 80tk
9 Dec 19
Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting
3:30pm
F-3
yhg9cb1g 239x
14 Nov 19
Shelf registration (foreign)
5:11pm
F-3
EX-1.2
28zypwg7bn mo95ttfc
14 Nov 19
Shelf registration (foreign)
5:11pm
6-K
EX-99.1
wymfjvn
11 Sep 19
Gamida Cell and the CIBMTR Announce Collaboration to Advance Research for Life-Saving Cellular Therapy
4:50pm
424B4
azkg90x5zsy91
28 Jun 19
Prospectus supplement with pricing info
3:51pm
F-1/A
gxt znw9dmblg
26 Jun 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-10.13
hbwbbva2a2 4i9m2v
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
EX-1.1
90pblr9qqjw5hmstjf
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
rpz8pgs3x475ax6d
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
EX-10.6
f1g0410g1gs3w7doh2
24 Jun 19
Registration statement (foreign)
4:04pm
6-K
EX-99.1
tltuwzsx27 9ybc
19 Jun 19
Gamida Cell and Lonza Establish Commercial Manufacturing Agreement for Omidubicel
6:02am
6-K
EX-99.1
sthcqu51 gk
1 May 19
Current report (foreign)
7:23am